Objective To construct pCTHRC1-IRES2-EGFP eukaryotic expression vector,and to investigate the association between collagen triple helix repeat containing 1( CTHRC1) gene and miR-30 b. Methods Specific primers were designed and PCR was used for the amplification and synthesis of the sequence of CTHRC1 CDS + 3 'UTR region,which was then cloned into the pIRES2-EGFP eukaryotic expression vector to obtain the p CTHRC1-IRES2-EGFP eukaryotic expression vector. Nhe I/Xho I double enzyme electrophoresis and sequencing were used for identification,and the lipofection method was used to evaluate the transfection efficiency of Huh7 and HepG2 cells.After miR-30 b mimic,control,p CTHRC1-IRES2-EGFP plasmid,and pIRES2-EGFP plasmid were transfected into 293 T cells,Western Blot and quantitative real-time PCR were used to measure the protein expression of CTHRC1 and the expression of miR-30 b at 48 hours after transfection. The association between CTHRC1 gene and miR-30 b was analyzed. The independent samples t-test was used for comparison between two groups. Results Nhe I/Xho I double enzyme digestion was performed for the p CTHRC1-IRES2-EGFP eukaryotic expression vector,and two fragments with a length of 5300 bp and 1100 bp were obtained,which was consistent with the expected results;the sequencing results also showed that the sequence was exactly the same as that published in GeneBank,suggesting that the pCTHRC1-IRES2-EGFP eukaryotic expression vector was constructed successfully. In the transfection of Huh7 and HepG2 cells,2 μg p CTHRC1-IRES2-EGFP plasmid had a transfection efficiency of 90% and 89%,respectively,while 4 μg p CTHRC1-IRES2-EGFP plasmid had a transfection efficiency of 85% and 83%,respectively. In 293 T cells,the expression of CTHRC1 decreased to the miR-30 b group( P <0. 05). The expression of miR-30 b decreased in the group with overexpressed CTHRC1( P < 0. 05). Conclusion The eukaryotic expression vector of pCTHRC1-IRES2-EGFP is successfully constructed,and the expression of CTHRC1 is negatively correlated with the expression of miR-30 b in 293 T cells.
[1] LI L,HU Z. MiR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling[J]. Transplantation,2018,102(5):312.
|
[2] ZHENG M,ZHOU Q,LIU X,et al. CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway[J]. Oncol Rep,2019,41(3):1531-1538.
|
[3] LI N,CHEN L,LIU C,et al. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma[J]. Hum Pathol,2019,85:235-241.
|
[4] LIU Y,ABULIMITI N,WANG C. Collagen triple helix repeat containing 1 expression in osteosarcoma:A new predictor of prognosis[J]. Ann Clin Lab Sci,2018,48(3):338-344.
|
[5] QUINTAVALLE C,DONNARUMMA E,IABONI M,et al. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells[J]. Oncogene,2013,32(34):4001-4008.
|
[6] GAZIEL-SOVRAN A,SEGURA MF,DI MICCO R,et al. miR-30b/30d regulation of Gal NAc transferases enhances invasion and immunosuppression during metastasis[J]. Cancer Cell,2011,20(1):104-118.
|
[7] HOU M,CHENG Z,SHEN H,et al. High expression of CTHRC1promotes EMT of epithelial ovarian cancer(EOC)and is associated with poor prognosis[J]. Oncotarget,2015,6(34):35813-35829.
|
[8] WANG P,WANG YC,CHEN XY,et al. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-beta1 and may be associated with metastasis in human gastric cancer[J]. Cancer Sci,2012,103(7):1327-1333.
|
[9] TAN F,LIU F,LIU H,et al. CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer:A new predictor for prognosis[J]. Med Oncol,2013,30(1):473.
|
[10] PARK EH,KIM S,JO JY,et al. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells[J]. Carcinogenesis,2013,34(3):694-702.
|
[11] LAI YH,CHEN J,WANG XP,et al. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer[J]. J Exp Clin Cancer Res,2017,36(1):92.
|
[12] QIN X,CHEN J,WU L,et al. MiR-30b-5p acts as a tumor suppressor,repressing cell proliferation and cell cycle in human hepatocellular carcinoma[J]. Biomed Pharmacother,2017,89:742-750.
|
[13] CHEN S,LI P,YANG R,et al. microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer[J]. Cancer Cell Int,2015,15:85.
|
[14] LIAO WT,YE YP,ZHANG NJ,et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS,PIK3CD and BCL2[J]. J Pathol,2014,232(4):415-427.
|
[15] ZHU ED,LI N,LI BS,et al. miR-30b,down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1[J].PLo S One,2014,9(8):e106049.
|
[16] LI Q,ZHANG X,LI N,et al. miR-30b inhibits cancer cell growth,migration,and invasion by targeting homeobox A1 in esophageal cancer[J]. Biochem Biophys Res Commun,2017,485(2):506-512.
|
[17] ICHIKAWA T,SATO F,TERASAWA K,et al. Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells[J]. PLo S One,2012,7(2):e31422.
|
[18] LI L,WANG B. Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma[J]. Int J Mol Sci,2014,15(11):19729-19740.
|
[19] ZHANG D,LIU Z,ZHENG N,et al. MiR-30b-5p modulates glioma cell proliferation by direct targeting MTDH[J]. Saudi J Biol Sci,2018,25(5):947-952.
|
[20] ZHOU X,HUANG L. DNA transfection mediated by cationic liposomes containing lipopolylysine:Characterization and mechanism of action[J]. Biochim Biophys Acta,1994,1189(2):195-203.
|